BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32273944)

  • 21. Anticancer therapeutic potential of Mn porphyrin/ascorbate system.
    Tovmasyan A; Sampaio RS; Boss MK; Bueno-Janice JC; Bader BH; Thomas M; Reboucas JS; Orr M; Chandler JD; Go YM; Jones DP; Venkatraman TN; Haberle S; Kyui N; Lascola CD; Dewhirst MW; Spasojevic I; Benov L; Batinic-Haberle I
    Free Radic Biol Med; 2015 Dec; 89():1231-47. PubMed ID: 26496207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rational design of superoxide dismutase (SOD) mimics: the evaluation of the therapeutic potential of new cationic Mn porphyrins with linear and cyclic substituents.
    Tovmasyan A; Carballal S; Ghazaryan R; Melikyan L; Weitner T; Maia CG; Reboucas JS; Radi R; Spasojevic I; Benov L; Batinic-Haberle I
    Inorg Chem; 2014 Nov; 53(21):11467-83. PubMed ID: 25333724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioprotective effect of a metalloporphyrin compound in rat eye model.
    Mao XW; Crapo JD; Mekonnen T; Lindsey N; Martinez P; Gridley DS; Slater JM
    Curr Eye Res; 2009 Jan; 34(1):62-72. PubMed ID: 19172472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New class of potent catalysts of O2.-dismutation. Mn(III) ortho-methoxyethylpyridyl- and di-ortho-methoxyethylimidazolylporphyrins.
    Batinić-Haberle I; Spasojević I; Stevens RD; Hambright P; Neta P; Okado-Matsumoto A; Fridovich I
    Dalton Trans; 2004 Jun; (11):1696-702. PubMed ID: 15252564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superoxide Dismutase Mimic, MnTE-2-PyP Enhances Rectal Anastomotic Strength in Rats after Preoperative Chemoradiotherapy.
    Yang Y; Wang Q; Luo J; Jiang Y; Zhou R; Tong S; Wang Z; Tong Q
    Oxid Med Cell Longev; 2020; 2020():3509859. PubMed ID: 32351671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MnTE-2-PyP Attenuates TGF-
    Yang Y; Zhang P; Yan R; Wang Q; Fang E; Wu H; Li S; Tan H; Zhou X; Ma X; Tang Y; Huang Y; Deng R; Liu Y; Tong S; Wang Z; Oberley-Deegan RE; Tong Q
    Oxid Med Cell Longev; 2019; 2019():8639791. PubMed ID: 30931081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acid-base and electrochemical properties of manganese meso(ortho- and meta-N-ethylpyridyl)porphyrins: potentiometric, spectrophotometric and spectroelectrochemical study of protolytic and redox equilibria.
    Weitner T; Budimir A; Kos I; Batinić-Haberle I; Biruš M
    Dalton Trans; 2010 Dec; 39(48):11568-76. PubMed ID: 21052598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pure MnTBAP selectively scavenges peroxynitrite over superoxide: comparison of pure and commercial MnTBAP samples to MnTE-2-PyP in two models of oxidative stress injury, an SOD-specific Escherichia coli model and carrageenan-induced pleurisy.
    Batinić-Haberle I; Cuzzocrea S; Rebouças JS; Ferrer-Sueta G; Mazzon E; Di Paola R; Radi R; Spasojević I; Benov L; Salvemini D
    Free Radic Biol Med; 2009 Jan; 46(2):192-201. PubMed ID: 19007878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early and late administration of MnTE-2-PyP5+ in mitigation and treatment of radiation-induced lung damage.
    Gauter-Fleckenstein B; Fleckenstein K; Owzar K; Jiang C; Rebouças JS; Batinic-Haberle I; Vujaskovic Z
    Free Radic Biol Med; 2010 Apr; 48(8):1034-43. PubMed ID: 20096348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.
    Batinic-Haberle I; Rajic Z; Tovmasyan A; Reboucas JS; Ye X; Leong KW; Dewhirst MW; Vujaskovic Z; Benov L; Spasojevic I
    Free Radic Biol Med; 2011 Sep; 51(5):1035-53. PubMed ID: 21616142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Redox modulation of oxidative stress by Mn porphyrin-based therapeutics: the effect of charge distribution.
    Rebouças JS; Spasojević I; Tjahjono DH; Richaud A; Méndez F; Benov L; Batinić-Haberle I
    Dalton Trans; 2008 Mar; (9):1233-42. PubMed ID: 18283384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a metalloporphyrin antioxidant (MnTE-2-PyP) on the response of a mouse prostate cancer model to radiation.
    Makinde AY; Luo-Owen X; Rizvi A; Crapo JD; Pearlstein RD; Slater JM; Gridley DS
    Anticancer Res; 2009 Jan; 29(1):107-18. PubMed ID: 19331139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MnTE-2-PyP disrupts Staphylococcus aureus biofilms in a novel fracture model.
    Lindsay SE; Lindsay HG; Kallet J; Weaver MR; Curran-Everett D; Crapo JD; Regan EA
    J Orthop Res; 2021 Nov; 39(11):2439-2445. PubMed ID: 33347639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MnTE-2-PyP Treatment, or NOX4 Inhibition, Protects against Radiation-Induced Damage in Mouse Primary Prostate Fibroblasts by Inhibiting the TGF-Beta 1 Signaling Pathway.
    Chatterjee A; Kosmacek EA; Oberley-Deegan RE
    Radiat Res; 2017 Mar; 187(3):367-381. PubMed ID: 28225655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of a metalloporphyrin antioxidant mimetic (MnTE-2-PyP) as a radiomitigator: prostate tumor and immune status.
    Mehrotra S; Pecaut MJ; Freeman TL; Crapo JD; Rizvi A; Luo-Owen X; Slater JM; Gridley DS
    Technol Cancer Res Treat; 2012 Oct; 11(5):447-57. PubMed ID: 22475066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A manganese porphyrin superoxide dismutase mimetic enhances tumor radioresponsiveness.
    Moeller BJ; Batinic-Haberle I; Spasojevic I; Rabbani ZN; Anscher MS; Vujaskovic Z; Dewhirst MW
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):545-52. PubMed ID: 16168847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MnTE-2-PyP, a manganese porphyrin, reduces cytotoxicity caused by irradiation in a diabetic environment through the induction of endogenous antioxidant defenses.
    Chatterjee A; Kosmacek EA; Shrishrimal S; McDonald JT; Oberley-Deegan RE
    Redox Biol; 2020 Jul; 34():101542. PubMed ID: 32361681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors.
    Keir ST; Dewhirst MW; Kirkpatrick JP; Bigner DD; Batinic-Haberle I
    Anticancer Agents Med Chem; 2011 Feb; 11(2):202-12. PubMed ID: 21291403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities.
    Batinic-Haberle I; Spasojevic I; Tse HM; Tovmasyan A; Rajic Z; St Clair DK; Vujaskovic Z; Dewhirst MW; Piganelli JD
    Amino Acids; 2012 Jan; 42(1):95-113. PubMed ID: 20473774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Septic diaphragmatic dysfunction is prevented by Mn(III)porphyrin therapy and inducible nitric oxide synthase inhibition.
    Nin N; Cassina A; Boggia J; Alfonso E; Botti H; Peluffo G; Trostchansky A; Batthyány C; Radi R; Rubbo H; Hurtado FJ
    Intensive Care Med; 2004 Dec; 30(12):2271-8. PubMed ID: 15349724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.